SPNS2 and acute myeloid leukemia: Our study disclosed the guiding significance of SPNS expression in prognosis of AML, high expression of SPNS2 and SPNS3 were poor prognosis in chemotherapy patients, and SPNS3 was a poor indicator for OS in allo-HSCT patients.